Insiders · Profile

Javitt Jonathan C

Chairman and Chief Scientist at NRX Pharmaceuticals. Filing since 1 Jun 2022. CIK 0001303782

Company
Date
Role
Action
Shares
Amount
Of holding
17 Dec 2024
Chairman and Chief Scientist
Bought
40,000
$46.80K
89.6%
23 Aug 2023
Chief Scientist
Bought
100,000
$33.00K
28.9%
22 Aug 2023
Chief Scientist
Bought
200,000
$64.40K
137%
7 Dec 2022
Director
Sold, plan not stated
400,000
$400.00K
3.0%
1 Jun 2022
Chief Scientist
Bought
100,000
$5.80M
216%
5 decisions on file.